211 related articles for article (PubMed ID: 23889214)
1. Patients with xeroderma pigmentosum complementation groups C, E and V do not have abnormal sunburn reactions.
Sethi M; Lehmann AR; Fawcett H; Stefanini M; Jaspers N; Mullard K; Turner S; Robson A; McGibbon D; Sarkany R; Fassihi H
Br J Dermatol; 2013 Dec; 169(6):1279-87. PubMed ID: 23889214
[TBL] [Abstract][Full Text] [Related]
2. [Xeroderma pigmentosum].
Takeuchi S
Nihon Rinsho; 2000 Jul; 58(7):1496-500. PubMed ID: 10921330
[TBL] [Abstract][Full Text] [Related]
3. Xeroderma pigmentosum: a Turkish case series.
Gül U; Kiliç A; Gönül M; Cakmak SK; Soylu S
Int J Dermatol; 2007 Nov; 46(11):1125-8. PubMed ID: 17988329
[TBL] [Abstract][Full Text] [Related]
4. Late onset of skin cancers in 2 xeroderma pigmentosum group F siblings and a review of 30 Japanese xeroderma pigmentosum patients in groups D, E and F.
Kondo S; Mamada A; Miyamoto C; Keong CH; Satoh Y; Fujiwara Y
Photodermatol; 1989 Apr; 6(2):89-95. PubMed ID: 2664729
[TBL] [Abstract][Full Text] [Related]
5. Molecular genetic analysis of 16 XP-C patients from Germany: environmental factors predominately contribute to phenotype variations.
Schäfer A; Hofmann L; Gratchev A; Laspe P; Schubert S; Schürer A; Ohlenbusch A; Tzvetkov M; Hallermann C; Reichrath J; Schön MP; Emmert S
Exp Dermatol; 2013 Jan; 22(1):24-9. PubMed ID: 23173980
[TBL] [Abstract][Full Text] [Related]
6. Xeroderma pigmentosum.
Lehmann AR; McGibbon D; Stefanini M
Orphanet J Rare Dis; 2011 Nov; 6():70. PubMed ID: 22044607
[TBL] [Abstract][Full Text] [Related]
7. Auditory analysis of xeroderma pigmentosum 1971-2012: hearing function, sun sensitivity and DNA repair predict neurological degeneration.
Totonchy MB; Tamura D; Pantell MS; Zalewski C; Bradford PT; Merchant SN; Nadol J; Khan SG; Schiffmann R; Pierson TM; Wiggs E; Griffith AJ; DiGiovanna JJ; Kraemer KH; Brewer CC
Brain; 2013 Jan; 136(Pt 1):194-208. PubMed ID: 23365097
[TBL] [Abstract][Full Text] [Related]
8. The present status of xeroderma pigmentosum in Japan and a tentative severity classification scale.
Nakano E; Masaki T; Kanda F; Ono R; Takeuchi S; Moriwaki S; Nishigori C
Exp Dermatol; 2016 Aug; 25 Suppl 3():28-33. PubMed ID: 27539899
[TBL] [Abstract][Full Text] [Related]
9. Report of three sisters with XP-E, a rare xeroderma pigmentosum complementation group.
Fischer E; Schnyder UW; Jung EG
Photodermatol; 1984 Oct; 1(5):232-6. PubMed ID: 6531300
[TBL] [Abstract][Full Text] [Related]
10. Clinical, genetic and DNA repair studies on a consecutive series of patients with xeroderma pigmentosum.
Pawsey SA; Magnus IA; Ramsay CA; Benson PF; Giannelli F
Q J Med; 1979 Apr; 48(190):179-210. PubMed ID: 504548
[TBL] [Abstract][Full Text] [Related]
11. Xeroderma pigmentosum: beyond skin cancer.
Lichon V; Khachemoune A
J Drugs Dermatol; 2007 Mar; 6(3):281-8. PubMed ID: 17373189
[TBL] [Abstract][Full Text] [Related]
12. Correlation of phenotype/genotype in a cohort of 23 xeroderma pigmentosum-variant patients reveals 12 new disease-causing POLH mutations.
Opletalova K; Bourillon A; Yang W; Pouvelle C; Armier J; Despras E; Ludovic M; Mateus C; Robert C; Kannouche P; Soufir N; Sarasin A
Hum Mutat; 2014 Jan; 35(1):117-28. PubMed ID: 24130121
[TBL] [Abstract][Full Text] [Related]
13. Association between DNA repair-deficiency and high level of p53 mutations in melanoma of Xeroderma pigmentosum.
Spatz A; Giglia-Mari G; Benhamou S; Sarasin A
Cancer Res; 2001 Mar; 61(6):2480-6. PubMed ID: 11289118
[TBL] [Abstract][Full Text] [Related]
14. A novel mutation in the XPA gene associated with unusually mild clinical features in a patient who developed a spindle cell melanoma.
Sidwell RU; Sandison A; Wing J; Fawcett HD; Seet JE; Fisher C; Nardo T; Stefanini M; Lehmann AR; Cream JJ
Br J Dermatol; 2006 Jul; 155(1):81-8. PubMed ID: 16792756
[TBL] [Abstract][Full Text] [Related]
15. Clinical and genetic characteristics of xeroderma pigmentosum in Nepal.
Espi P; Parajuli S; Benfodda M; Lebre AS; Paudel U; Grange A; Grybek V; Grange T; Soufir N; Grange F
J Eur Acad Dermatol Venereol; 2018 May; 32(5):832-839. PubMed ID: 29178624
[TBL] [Abstract][Full Text] [Related]
16. Clinical and molecular epidemiological study of xeroderma pigmentosum in China: A case series of 19 patients.
Zhou EY; Wang H; Lin Z; Xu G; Ma Z; Zhao J; Feng C; Duo L; Yin J; Yang Y
J Dermatol; 2017 Jan; 44(1):71-75. PubMed ID: 27607234
[TBL] [Abstract][Full Text] [Related]
17. Xeroderma pigmentosum variant with multisystem involvement.
Hessel A; Siegle RJ; Mitchell DL; Cleaver JE
Arch Dermatol; 1992 Sep; 128(9):1233-7. PubMed ID: 1519938
[TBL] [Abstract][Full Text] [Related]
18. Clinical symptoms and DNA repair characteristics of xeroderma pigmentosum patients from Germany.
Thielmann HW; Popanda O; Edler L; Jung EG
Cancer Res; 1991 Jul; 51(13):3456-70. PubMed ID: 2054785
[TBL] [Abstract][Full Text] [Related]
19. Reduced levels of UV-induced unscheduled DNA synthesis in epidermal keratinocytes of patients with xeroderma pigmentosum and correlation with development of skin neoplasms.
Kondo S; Satoh Y; Kuroki T
Cancer Res; 1989 Apr; 49(8):1927-30. PubMed ID: 2467739
[TBL] [Abstract][Full Text] [Related]
20. Deep phenotyping of 89 xeroderma pigmentosum patients reveals unexpected heterogeneity dependent on the precise molecular defect.
Fassihi H; Sethi M; Fawcett H; Wing J; Chandler N; Mohammed S; Craythorne E; Morley AM; Lim R; Turner S; Henshaw T; Garrood I; Giunti P; Hedderly T; Abiona A; Naik H; Harrop G; McGibbon D; Jaspers NG; Botta E; Nardo T; Stefanini M; Young AR; Sarkany RP; Lehmann AR
Proc Natl Acad Sci U S A; 2016 Mar; 113(9):E1236-45. PubMed ID: 26884178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
